Graziella Pellegrini, Italy

Graziella Pellegrini is Full Professor at the University of Modena and Reggio Emilia and Cell Therapy Coordinator at the Centre for Regenerative Medicine. She was co-founder of Holostem Terapie Avanzate S.r.l.   She has two Master Degrees in Chemistry and Pharmaceutical Technologies and in Pharmacy at the University of Genova. She was one of the two inventors of the technology for culture and transplantation of limbal stem cells for the treatment of blindness due to LSCD; she obtained the orphan drug designation and European registration of the therapy at European Medicine Agency. Prof. Pellegrini developed translational medicine protocols for third-degree burns, depigmentation disorders and phase I clinical trial on gene therapy of epidermolysis bullosa. She was working on oral mucosa and urethra,  airway tissue reconstruction and full cornea TE.Author of 14 patents, book chapters and international peer reviewed publications in the major international peer-review journals, as New England Journal of Medicine, Nature, Lancet, she was invited speaker or chairman in over 250 major scientific meetings and more than 80 lessons all over the world. She is founding member of the International Ocular Surface Society, member of major scientific societies and international committees. She was awarded by ISSCR, Termis EU carrier award, Italian government, Department of international Trade, Louis Jeantet-Collen Prize, FEBS award, San Silvestro Academy, Foundation Gabriella Fabbrocini and ISSCR public service award.